Rockwell Medical Inc.

NASDAQ: RMTI · Real-Time Price · USD
1.02
-0.03 (-2.86%)
At close: Aug 15, 2025, 3:59 PM
1.03
0.97%
After-hours: Aug 15, 2025, 07:22 PM EDT

Rockwell Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
87.97M 97.73M 101.49M 98.92M 94.37M 86.62M 83.61M 80.83M 75.75M 76.35M 72.81M 68.83M 66.13M 62.58M 61.93M 61.76M 61.05M 61.81M
Cost of Revenue
72.55M 80.27M 84M 82.19M 81.69M 77.45M 74.91M 72.66M 69M 68.89M 68.73M 69.32M 67.73M 66.19M 64.35M 61.57M 60.18M 59.8M
Gross Profit
15.41M 17.46M 17.48M 16.72M 12.69M 9.17M 8.7M 8.17M 6.75M 7.46M 4.08M -495K -1.6M -3.61M -2.42M 195K 870K 2.01M
Operating Income
-1.29M 572K 608K 580K -3.09M -6.57M -6.67M -8.09M -10.06M -11.58M -16.78M -23.18M -26.44M -29.78M -30.34M -30.05M -29.77M -27.55M
Interest Income
194K 134K 92K 105K 131K 171K 211K 214K 158K 109K 45K 5K 5K 12K 23K 18K 20K 79.75K
Pretax Income
-2.1M -264K -480K -1.24M -4.77M -8.42M -8.44M -9.29M -11.61M -13.27M -18.68M -25.26M -28.65M -32.08M -32.67M -32.4M -32.16M -30.66M
Net Income
-2.1M -264K -480K -1.24M -4.77M -8.42M -9.15M -10.39M -13.19M -15.34M -20.58M -26.76M -29.67M -32.62M -32.67M -32.4M -32.16M -30.66M
Selling & General & Admin
16.71M 16.89M 16.86M 15.96M 15.1M 14.89M 14.27M 15.17M 15.74M 17.21M 17.74M 18.33M 19.73M 19.58M 21.08M 22.89M 22.76M 22.48M
Research & Development
1K 1K 19K 186K 680K 847K 1.11M 1.09M 1.07M 1.83M 3.12M 4.35M 5.1M 6.59M 6.84M 7.36M 7.88M 7.08M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
16.71M 16.89M 16.88M 16.14M 15.78M 15.74M 15.37M 16.26M 16.81M 19.04M 20.86M 22.68M 24.84M 26.17M 27.91M 30.24M 30.64M 29.56M
Interest Expense
592K 1.1M 1.25M 2.07M 2.18M 2.35M 2.3M 1.63M 1.7M 1.79M 1.95M 2.1M 2.22M 2.32M 2.36M 2.36M 2.42M 2.36M
Selling & Marketing Expenses
2.85M 2.87M 2.75M 2.45M 2.28M 2.22M 2.13M 1.94M 2.14M 2.14M 2.1M 2.62M 3.4M 4.34M 5.73M 6.99M 7.12M 7.65M
Cost & Expenses
89.26M 97.16M 100.88M 98.34M 97.47M 93.19M 90.28M 88.92M 85.81M 87.94M 89.59M 92M 92.56M 92.36M 92.27M 91.81M 90.82M 89.36M
Income Tax Expense
n/a n/a n/a n/a n/a n/a 710K 1.1M 1.59M 2.07M 1.9M 1.5M 1.02M 536K 11K 11K 11K -305.72K
Shares Outstanding (Basic)
34.31M 34.11M 32.88M 31.55M 30.45M 29.33M 28.65M 27.52M 18.5M 18.36M 11.55M 10.53M 8.81M 8.54M 8.53M 8.53M 8.48M 8.51M
Shares Outstanding (Diluted)
34.31M 34.11M 32.88M 32.42M 32.03M 29.33M 28.65M 27.52M 18.5M 18.36M 11.55M 10.53M 8.81M 8.55M 8.53M 8.53M 8.52M 8.51M
EPS (Basic)
-0.06 -0.01 -0.02 -0.05 -0.17 -0.36 -0.43 -0.62 -0.99 -1.43 -2.2 -3.01 -3.46 -3.83 -3.84 -4.12 -4.36 -4.46
EPS (Diluted)
-0.07 -0.01 -0.02 -0.05 -0.17 -0.36 -0.43 -0.62 -0.99 -1.43 -2.2 -3.01 -3.46 -3.83 -3.84 -4.12 -4.36 -4.46
EBITDA
-125K 2.35M 2.95M 3.02M -382K -4.25M -4.21M -5.63M -8.29M -9.9M -15.66M -22.07M -24.88M -27.73M -27.8M -27.6M -27.37M -26M
EBIT
262K 837K 775K 837K -2.59M -6.08M -6.14M -7.67M -9.91M -11.49M -16.75M -23.16M -26.43M -29.76M -30.31M -30.03M -29.75M -28.3M
Depreciation & Amortization
1.62M 2.17M 2.18M 2.19M 2.21M 2.36M 2.46M 2.56M 2.63M 2.58M 2.59M 2.61M 2.58M 2.56M 2.52M 2.43M 2.38M 2.3M